Liwei Chen

Title: Liwei Chen: Innovator in Nucleobase Editing Technologies

Introduction

Liwei Chen is a prominent inventor based in Somerville, MA (US). He has made significant contributions to the field of genetic engineering, particularly in the area of nucleobase editing. His innovative work has the potential to revolutionize how genetic modifications are approached in various applications.

Latest Patents

Liwei Chen holds a patent titled "Nucleobase editors comprising nucleic acid programmable DNA binding proteins." This patent outlines strategies, systems, reagents, methods, and kits that facilitate the targeted editing of nucleic acids. The technology allows for precise editing at a single site within the genome of a cell or subject, including the human genome. The patent also describes fusion proteins of nucleic acid programmable DNA binding proteins (napDNAbp) and nucleic acid editing proteins or protein domains, such as deaminase domains. These advancements provide methods and reagents for generating targeted nucleic acid editing proteins.

Career Highlights

Liwei Chen is affiliated with Harvard College, where he continues to advance his research in genetic editing technologies. His work has garnered attention for its innovative approach to nucleic acid manipulation, which is crucial for various scientific and medical applications.

Collaborations

Liwei Chen has collaborated with notable researchers in his field, including David R Liu and Alexis Christine Komor. These collaborations have further enhanced the impact of his work and contributed to the development of cutting-edge technologies in genetic editing.

Conclusion

Liwei Chen's contributions to nucleobase editing technologies exemplify the innovative spirit of modern science. His patent and ongoing research at Harvard College position him as a key figure in the advancement of genetic engineering.